Neuraxis Inc. Insider Trading

NRXS

Cluster buy

3 insiders bought 12K of their own stock in 1 day.

Open-market purchases by executives and directors between Oct 8 and Oct 8. Buying is rarer than selling and says more, but it is one input, not a verdict.

Net open-market

+$1.05M

7 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

4 / 0

executives and directors

Last open-market buy

Oct 2026

Oct 8, 2026

Get an email when NRXS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 8	Brian Allen Carrico Chief Executive Officer	Bought	268	$4.84	1K	0.1%	Form 4
Oct 8	Thomas Joeseph Carrico Cro, CCO, Cpo	Bought	328	$4.84	2K	0.2%	Form 4
Oct 8	Timothy Robert Henrichs Chief Financial Officer	Bought	1,937	$4.84	9K	26%	Form 4
Apr 1	Timothy Robert Henrichs Chief Financial Officer	Bought	7,593	$1.96	15K	New	Form 4
Apr 1	Thomas Joeseph Carrico Cro, CCO, Cpo	Bought	667	$1.96	1K	0.2%	Form 4
Apr 1	Brian Allen Carrico Chief Executive Officer	Bought	8,060	$1.96	16K	2.4%	Form 4
Feb 11 – 12	Brian Hannasch Large holder	Bought 2 parts	80,000	$4.79 average	383K	7.1%	Form 4
Dec 23, 2025	Gil Aharon Director	Bought	286,138	$3.52	$1.01M	New	Form 4
Jul 1, 2025	Brian Hannasch Large holder	Bought	355,556	$2.25	800K	46%	Form 4
Jul 1, 2025	Masimo Corp Large holder	SoldNo plan 2 parts	821,327	$2.25 average	$1.85M	100%	Form 4
Apr 21, 2025	Brian Hannasch Large holder	Bought	18,065	$1.73	31K	2.4%	Form 4

Oct 8
Brian Allen Carrico
Chief Executive Officer · bought 268 at $4.84
1K
0.1% of stake
Oct 8
Thomas Joeseph Carrico
Cro, CCO, Cpo · bought 328 at $4.84
2K
0.2% of stake
Oct 8
Timothy Robert Henrichs
Chief Financial Officer · bought 1,937 at $4.84
9K
26% of stake
Apr 1
Timothy Robert Henrichs
Chief Financial Officer · bought 7,593 at $1.96
15K
New position
Apr 1
Thomas Joeseph Carrico
Cro, CCO, Cpo · bought 667 at $1.96
1K
0.2% of stake
Apr 1
Brian Allen Carrico
Chief Executive Officer · bought 8,060 at $1.96
16K
2.4% of stake
Feb 11 – 12
Brian Hannasch
Large holder · bought 80,000 at avg $4.79
383K
7.1% of stake
Dec 23, 2025
Gil Aharon
Director · bought 286,138 at $3.52
$1.01M
New position
Jul 1, 2025
Brian Hannasch
Large holder · bought 355,556 at $2.25
800K
46% of stake
Jul 1, 2025No plan
Masimo Corp
Large holder · sold 821,327 at avg $2.25
$1.85M
100% of stake
Apr 21, 2025
Brian Hannasch
Large holder · bought 18,065 at $1.73
31K
2.4% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch NRXS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Electromedical & Electrotherapeutic Apparatus · Pick stocks to compare with NRXS

CompareIntrinsic value

ADMTAdm Tronics Unlimited Inc.

$0.07+0.00%18

NUWENuwellis Inc.

$5.27-10.83%35

GTHPGuided Therapeutics Inc.

$0.10-33.33%30

ESMCEscalon Medical Corp

$0.19+4.00%20

CVCapsoVision, Inc.

$6.85+2.24%21

HYPRHyperfine Inc.

$0.75+8.38%40

QTIQT Imaging Holdings, Inc.

$2.19+1.39%0

POCIPrecision Optics Corporation, Inc.

$4.84+3.42%25

Held by ETFs

NRXS is in 1 US ETF. The largest of them, with NRXS's weight in each:

iShares Micro-Cap ETFIWC0.02%of the fund

Spot a number that looks wrong? Check it in NRXS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NRXS

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.